Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen PS Ratio
PS Ratio Chart
Historical PS Ratio Data
| Date | Value |
|---|---|
| February 13, 2024 | 28.89 |
| February 12, 2024 | 28.89 |
| February 09, 2024 | 28.89 |
| February 08, 2024 | 28.89 |
| February 07, 2024 | 27.34 |
| February 06, 2024 | 27.30 |
| February 05, 2024 | 27.11 |
| February 02, 2024 | 27.07 |
| February 01, 2024 | 27.16 |
| January 31, 2024 | 27.12 |
| January 30, 2024 | 27.19 |
| January 29, 2024 | 27.22 |
| January 26, 2024 | 27.36 |
| January 25, 2024 | 27.29 |
| January 24, 2024 | 27.29 |
| January 23, 2024 | 27.24 |
| January 22, 2024 | 27.33 |
| January 19, 2024 | 27.31 |
| January 18, 2024 | 27.32 |
| January 17, 2024 | 27.37 |
| January 16, 2024 | 27.41 |
| January 12, 2024 | 27.53 |
| January 11, 2024 | 27.48 |
| January 10, 2024 | 27.53 |
| January 09, 2024 | 27.65 |
| Date | Value |
|---|---|
| January 08, 2024 | 27.61 |
| January 05, 2024 | 27.43 |
| January 04, 2024 | 27.31 |
| January 03, 2024 | 27.29 |
| January 02, 2024 | 27.44 |
| December 29, 2023 | 27.43 |
| December 28, 2023 | 27.48 |
| December 27, 2023 | 27.63 |
| December 26, 2023 | 27.61 |
| December 22, 2023 | 27.48 |
| December 21, 2023 | 27.48 |
| December 20, 2023 | 27.26 |
| December 19, 2023 | 27.62 |
| December 18, 2023 | 27.26 |
| December 15, 2023 | 27.24 |
| December 14, 2023 | 27.26 |
| December 13, 2023 | 27.71 |
| December 12, 2023 | 27.48 |
| December 11, 2023 | 27.43 |
| December 08, 2023 | 27.02 |
| December 07, 2023 | 27.17 |
| December 06, 2023 | 27.14 |
| December 05, 2023 | 27.02 |
| December 04, 2023 | 27.03 |
| December 01, 2023 | 27.12 |
Price to Sales Ratio Definition
The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.
PS Ratio Range, Past 5 Years
3.822
Minimum
Mar 18 2020
42.41
Maximum
Jun 23 2023
12.41
Average
10.20
Median
Nov 05 2021
PS Ratio Benchmarks
| AbbVie Inc | 5.338 |
| Pfizer Inc | 2.968 |
| Johnson & Johnson | 4.273 |
| Merck & Co Inc | 5.454 |
| Cerevel Therapeutics Holdings Inc | -- |
PS Ratio Related Metrics
| Price | 31.23 |